Ireland· IE-PA-EU/1/02/226/001
InductOs 1.5 mg/ml powder, solvent and matrix for implantation matrix
A dibotermin alfa product containing dibotermin alfa, registered in Ireland by Medtronic BioPharma B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Dibotermin alfa is registered in 11 of 19 countries.
Countries holding a registration under ATC M05BC01 (dibotermin alfa), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Dibotermin alfa · ATC M05BC01
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- Dibotermin alfa
- Manufacturer
- Medtronic BioPharma B.V.
- Country
- Ireland (IE)
- ATC code
- M05BC01
- ATC class
- Dibotermin alfa
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/02/226/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dibotermin alfa in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceINDUCTOS 1,5 mg/ml, poudre, solvant et matrice pour matrice implantableMEDTRONIC BIOPHARMA (PAYS-BAS)
- United KingdomInductOs 12mg powder and solvent and matrix for implantation matrixMedtronic Ltd
- SwitzerlandInductOs 1.5 mg/ml, poudre 12 mg, solvant et matrice pour matrice pour implantationMedtronic BioPharma Sàrl
- FinlandInductosMedtronic BioPharma B. V.
- CzechiaINDUCTOSMedtronic BioPharma B.V., Heerlen
- BelgiumInductOs 1.5 mg/mlMedtronic Biopharma
- PolandInductOsMedtronic BioPharma B.V.
- SwedenInductOs 1,5 mg/ml Pulver, vätska och matrix till matrix för implantationMedtronic BioPharma B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Inductos
- Liechtenstein · Inductos
- Norway · Inductos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1446403f-1a56-4138-a32d-436bfdcd52c7 GET /v1/drugs/1446403f-1a56-4138-a32d-436bfdcd52c7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder, solvent and matrix for implantation matrix",
"routes": [
"Implantation"
],
"source": "hpra",
"atc_all": [
"M05BC",
"M05BC01"
],
"strength": null,
"pa_number": "EU/1/02/226/001",
"substances": [
"Dibotermin alfa"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "09/09/2002",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about dibotermin alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.